Table 1.
Demographic characteristics of patients who underwent salvage surgery
| Characteristic | Patients (n = 70) |
|---|---|
| Median age (range), years | 54 (23–75) |
| Age, mean years ± SD | 53.8±11.4 |
| Age, n (%) | |
| <65 years | 60 (85.7) |
| ≥65 years | 10 (14.3) |
| Sex, n (%) | |
| Female | 9 (12.9) |
| Male | 61 (87.1) |
| ECOG-PS, n (%) | |
| 0 | 63 (90) |
| 1 | 7 (10) |
| Hepatitis B infection, n (%) | |
| Yes | 64 (91.4) |
| No | 6 (8.6) |
| Pre-treatment AFP, n (%) | |
| <400 ng/mL | 30 (42.9) |
| ≥400 ng/mL | 40 (57.1) |
| Pre-treatment PIVKA-II, n (%) | |
| <400 mAU/mL | 12 (17.1) |
| ≥400 mAU/mL | 58 (82.9) |
| Number of tumors, n (%) | |
| Single | 23 (32.9) |
| Multiple | 47 (67.1) |
| Maximum tumor size, cm | 10.5±4.85 |
| Maximum tumor size, n (%) | |
| <10 cm | 30 (42.9) |
| ≥10 cm | 40 (57.1) |
| Macrovascular invasion, n (%) | 39 (55.7) |
| BCLC staging, n (%) | |
| A | 9 (12.9) |
| B | 22 (31.4) |
| C | 39 (55.7) |
| CNLC staging, n (%) | |
| Ib | 9 (12.9) |
| IIa | 9 (12.9) |
| IIb | 13 (18.6) |
| IIIa | 39 (55.7) |
SD, standard deviations; ECOG-PS, Eastern Cooperative Oncology Group performance status; AFP, alpha fetoprotein; PIVKA-II, protein induced by vitamin K absence-II; BCLC, Barcelona Clinic Liver Cancer; CNLC, China Liver Cancer.